Neuropsychiatric assessment as a secondary outcome measure in a multiple sclerosis intravenous immunoglobulin L(IMg) trial.

Barak, Y

Neuropsychiatric assessment as a secondary outcome measure in a multiple sclerosis intravenous immunoglobulin L(IMg) trial. [electronic resource] - International journal of psychiatry in clinical practice 1999 - 31-4 p. digital

Publication Type: Journal Article

1365-1501

10.3109/13651509909024756 doi